Mitä Tarkoittaa PLUĆNIM Englanniksi - Englanniksi Käännös

• pulmonary
• lung

Esimerkkejä Plućnim käytöstä Kroaatti ja niiden käännökset Englanti

Što znaš o plućnim virusima tipa 3?
What do you know about type III pneumonic viruses?

I vodi bolestima poput emfizema pluća i drugim plućnim problemima.
And to diseases such as emphysema and other lung problems.

Bolesnici s plućnim infiltratima ili pneumonijom u nedavnoj anamnezi, mogu biti izloženi većem riziku.
Patients with a recent history of lung infiltrates or pneumonia may be at higher risk.

Umnožen na ljudskim diploidnim plućnim(WI-38) fibroblastima.
Produced in human diploid lung(WI-38) fibroblasts.

U 2 od 4 bolesnika s plućnim metastazama radioaktivnost je bila povezana s plućnim metastazama.
In 2 of 4 patients with lung metastases, radioactivity was associated with lung metastases.

Hiperhidriranih bolesnika, uključujući bolesnike s plućnim edemom.
Hyperhydrated patients, including patients with lung oedema.

S herpetičkim infekcijama u plućnim oblicimapropisati dva miligrama jedanput ili dvaput dnevno sublingvalno.
With herpetic infections in the lung formsprescribe two milligrams once or twice a day sublingually.

Otkrivanje nedostatka alfa-1-antitripsina u djece s plućnim bolestima.
Detection of a1-antitrypsin deficiency in children with lung diseases.

Kao i u svih bolesnika s plućnim komplikacijama u anamnezi, liječnik mora imati na umu moguću pojavu bronhospazma.
As with all patients with a history of pulmonary complications the physician should be aware of the possible occurrence of bronchospasm.

Ima blagu groznicu koju možemo da povežemo… sa srcem, plus plućnim čirom.
He's running a slight fever, which we can add to the heart, plus the lung ulcers.

Rečeno nam je da liječimo ljude koji su nam dovedeni s plućnim problemima, poput ljudi s zaraznom bolešću zvanom Covid-19.
He said,"We were told to treat people with lung problems that come to us as people who have an infectious disease called Covid-19.".

U opstrukcijskim plućnim patologijama u kroničnoj i dobi od 1 godine(zbog vjerojatnosti noćne apneje), lijek se primjenjuje s krajnjim oprezom.
In obstructive pulmonary pathologies in chronic and at the age of 1 year(due to the likelihood of nocturnal apnea), the drug is administered with extreme caution.

Ima blagu groznicu, koju možemo dodati problemu sa srcem i plućnim krvarenjima.
He's running a slight fever, which we can add to the heart, plus the lung ulcers.

Ne smije se davati bolesnicima s akutnim difuznim infiltrativnim plućnim poremećajem ili perikardnom bolesti bolesti koja utječe na vrećicu koja okružuje srce.
It must not be given to patients with acute diffuse infiltrative pulmonary disease or pericardial disease disease affecting the sac that surrounds the heart.

Osim u kavernoznom tijelu penisa, enzim PDE5 se nalazi i u plućnim krvnim žilama.
Apart from the presence of this enzyme in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature.

Javlja se kad postoji zadebljanje u plućnim venama, što desnu stranu srca tjera na prekovremeni rad i uzrokuje ono što nazivam obrnutim Grinchovim efektom.
It happens when there's a thickening in the pulmonary veins, making the right side of the heart work overtime, and causing what I call the reverse-Grinch effect.

Uptravi je lijek koji se primjenjuje u liječenju odraslih osoba s plućnom arterijskom hipertenzijom PAH, abnormalno visoki krvni tlak u plućnim arterijama.
Uptravi is a medicine used to treat adults with pulmonary arterial hypertension PAH, abnormally high blood pressure in the arteries of the lungs.

Odrasli propisuju tablete od 1 i 10 miligramas kroničnim plućnim infekcijama, herpetičke lezije(uključujući oftalmoherpes uključujući), virusni hepatitis C i B u kroničnom obliku.
Adults prescribe tablets of 1 and 10 milligramswith chronic pulmonary infections, herpetic lesions(with ophthalmoherpes including), viral hepatitis C and B in chronic form.

Osetogenesis imperfecta ponekad je praćena i plavim bjeloočnicama, stanjem dentinogenesis imperfecta, gubitkom sluha, patuljastim rastom, plućnim i ostalim problemima.
OI is sometimes also accompanied by blue sclera, dentinogenesis imperfecta known as glassy teeth, hearing loss, dwarfism, pulmonary complications and other problems.

Lijekove za giht, poput kolhicina lijekove za liječenje visokoga krvnog tlaka u plućnim arterijama(bolest poznata pod nazivom plućna arterijska hipertenzija), poput bosentana.
Medicines for gout, such as colchicine medicines used to treat high blood pressure in the arteries of the lungs(a disease known as pulmonary arterial hypertension) such as bosentan.

Uspordjivanje izmjerenih vrijednosti plućne funkcije s predvidjenim normalama upućuje na opstruktivne promjene naročitopri malim plućnim volumenima.
Comparison of preshift measuredventilatory capacity tests with predicted normal valuesindicates that these workers demonstrate obstructive changesaffecting primarily flow rates at low lung volumes.

Većina ljudi udiše spore Aspergillusa, i pritom se ne razbole, ali osobe s oslabljenim imunitetom ili plućnim bolestima imaju veći rizik od razvoja zdravstvenih problema zbog Aspergillusa.
Most people breathe in Aspergillus spores every day without becoming ill, however people with weakened immune systems or lung diseases are at a higher risk of developing health problems due to Aspergillus.

Bakterijske infekcije, upala ili infekcija unutarnje ovojnice srca, tuberkuloza, infekcija kosti, upala limfnih čvorova, kronično proširenje dišnih puteva u plućima s čestim plućnim infekcijama.
Bacterial infections, inflammation or infection of the inner layer of the heart, tuberculosis, bone infection, inflammation of the lymph nodes, chronic dilation of the airways in the lungs with frequent lung infections.

Abstracts Churg-Straussov sindrom(CSS) je nekrotizirajući vaskulitis malih krvnih žila koji je znakovito obilježen astmom, plućnim infiltracijama, ekstravaskularnim nekrotizirajućim granulomima i hipereozinofilijom.
Abstracts Churg-Strauss syndrome(CSS) is a small-vessel necrotizing vasculitis typically characterized by asthma, lung infiltrates, extravascular necrotizing granulomas and hypereosinophilia.

Tijekom kontrastne ehokardiografije javile su se ozbiljne kardiopulmonalne reakcije, uključujući smrtne slučajeve, za vrijeme ili u roku od 30 minuta od primjene Luminityja u bolesnika, uključujući one s teškim srčanim ili plućnim bolestima vidjeti dio 4.8.
During contrast-enhanced echocardiography, serious cardiopulmonary reactions, including fatalities, have occurred during or within 30 minutes of Luminity administration in patients including those with severe cardiac and pulmonary diseases see section 4.8.

U podacima prikupljenima nakon stavljanja u promet i u jednom posebnom kliničkom ispitivanju u bolesnika s prethodnim plućnim komplikacijama, bronhospazam je prijavljen kao štetni događaj koji bi mogao biti povezan s primjenom lijeka.
In post-marketing data and in one dedicated clinical trial in patients with a history of pulmonary complications, bronchospasm was reported as a possibly related adverse event.

Osim navedenog, sudjelovala je i u istraživanjima genetski modificiranog kvasca kao modela za istraživanje lipidne peroksidacije, te u istraživanju metabolizma željeza na eksperimentalnom modelu i u bolesnika s kožnom bolesti Rozacejom ili plućnim tumorima.
In addition she has participated in the use of genetically modified yeast as a model for the study of lipid peroxidation. She has also been involved in studies of iron metabolism both in experimental models and in patients with the skin disease Rozacea or lung tumors.

Ona su obuhvaćala ispitivanje potvrde doze kod mladih purana koji su umjetno zaraženi plućnim virusom(pneumovirus ptičje gripe) i bakterijom Ornithobacterium rhinotracheale radi oponašanja komplicirane infekcije.
These included a dose confirmation study in turkey poults(young turkeys) artificially infected with a lung virus(avian pneumovirus) and Ornithobacterium rhinotracheale, to simulate a complicated infection.

Na osnovi in vitro podataka i/ili iskustava iz kliničkih ispitivanja, može se očekivati sljedeća osjetljivost organizama povezanih s plućnim infekcijama kod CF-a na TOBI Podhaler.
Based upon in vitro data and/or clinical trial experience, the organisms associated with pulmonary infections in CF may be expected to respond to TOBI Podhaler therapy as follows.

Osim toga, u bolesnika s opstruktivnim plućnim poremećajem u anamnezi potrebno je razmotriti postinfuzijsku primjenu lijekova(npr. inhalacijskih kortikosteroida, kratkodjelujućih i dugodjelujućih bronhodilatatora) za zbrinjavanje respiratornih komplikacija, ako se pojave vidjeti dio 4.2.
Additionally the use of post-infusion medications(e.g. inhaled corticosteroids, short and long acting bronchodilators) should be considered for patients with a history of obstructive pulmonary disorder to manage respiratory complications should they occur see section 4.2.